Aeolus Pharmaceuticals, Inc.

CIK 1261734 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aeolus Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Dec 22, 201715-12G0001654954-17-011850
Aug 14, 201710-Q0001654954-17-007580
May 15, 201710-Q0001654954-17-004754
Mar 24, 20178-K0001654954-17-002402
Feb 17, 201710-Q0001654954-17-001178
Feb 14, 2017NT 10-Q0001654954-17-001034
Jan 30, 201710-K/A0001654954-17-000590
Dec 30, 201640001102624-16-003743
Dec 20, 201610-K0001199073-16-000300
Dec 20, 2016S-10001199073-16-000302
Sep 13, 20168-K0001199073-16-000207
Aug 15, 201610-Q0001102624-16-003292
May 26, 20168-K0001102624-16-002881
May 16, 201610-Q/A0001102624-16-002806
May 16, 201610-Q0001102624-16-002788
Apr 19, 2016DEF 14C0001102624-16-002569
Mar 23, 2016PRE 14C0001102624-16-002368
Feb 23, 20168-K0001102624-16-002174
Feb 16, 201610-Q0001102624-16-002135
Feb 16, 2016SC 13G/A0000921895-16-003414
Feb 12, 2016EFFECT9999999995-16-003768
Feb 12, 2016S-1/A0001102624-16-002117
Feb 8, 201640001102624-16-002092
Feb 3, 201640001102624-16-002066
Feb 3, 201640001102624-16-002068